The breakthrough in applying CAR-T therapy to autoimmunity came with the report by Mackensen et al. in 2022, describing five young adults with severe, refractory SLE who achieved drug-free remission following a single infusion of autologous CD19-directed CAR-T cells [10]. The gene discussed is CD19; the disease is systemic lupus erythematosus.